These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8407058)

  • 1. Tissue specificity of translation inhibition in Sprague-Dawley rats following in vivo cyclosporin A.
    Buss WC; Stepanek J
    Int J Immunopharmacol; 1993 Aug; 15(6):775-82. PubMed ID: 8407058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the inhibition of renal translation in the Sprague-Dawley rat following in vivo cyclosporin A.
    Buss WC; Stepanek J
    Int J Immunopharmacol; 1993 Jan; 15(1):63-76. PubMed ID: 8432624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new proposal for the mechanism of cyclosporine A nephrotoxicity. Inhibition of renal microsomal protein chain elongation following in vivo cyclosporine A.
    Buss WC; Stepanek J; Bennett WM
    Biochem Pharmacol; 1989 Nov; 38(22):4085-93. PubMed ID: 2597185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dose-dependent inhibition of rat renal translation elongation seen after in vivo cyclosporin A is not caused by cyclosporin metabolites.
    Buss WC; Bowers LD
    Toxicology; 1995 Jun; 100(1-3):17-25. PubMed ID: 7624874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tissue-specific changes in translation elongation after cyclosporin with changes in elongation factor 2 phosphorylation.
    Buss WC; Stepanek J; Queen SA
    Biochem Pharmacol; 1994 Oct; 48(7):1459-69. PubMed ID: 7945446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-induced renal dysfunction: correlations between cellular events and whole kidney function.
    Bennett WM; Houghton DC; Buss WC
    J Am Soc Nephrol; 1991 May; 1(11):1212-9. PubMed ID: 1932633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of decreases in renal cellular energetics and recovery of renal microsomal translation during chronic cyclosporine A administration.
    Buss WC; Griffey R
    Biochem Pharmacol; 1991 Jun; 42(1):71-6. PubMed ID: 2069599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: species/dose comparisons and possible mechanism.
    Santostefano MJ; Johnson KL; Whisnant NA; Richardson VM; DeVito MJ; Diliberto JJ; Birnbaum LS
    Fundam Appl Toxicol; 1996 Dec; 34(2):265-75. PubMed ID: 8954756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of verapamil on cyclosporine. A (CsA)-induced nephropathy in ischemic kidney model in rats: changes in systemic hemodynamics and hepatic and renal microsomal cytochrome P-450].
    Kishimoto T; Tsujino T; Nakatani T; Kim T; Ohyama A; Yoshimura R; Sakamoto W; Maekawa T; Kawashima H; Kusunose E
    Hinyokika Kiyo; 1991 Oct; 37(10):1159-64. PubMed ID: 1755405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An underlying role for hepatobiliary dysfunction in cyclosporine A nephrotoxicity.
    Aleo MD; Doshna CM; Fritz CA
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):126-34. PubMed ID: 18407308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
    Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
    Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between total kidney cyclosporin A concentrations, trough drug levels and renal function in the rat following withdrawal of treatment.
    Mead JC; Brown PA; Whiting PH
    Hum Exp Toxicol; 1994 Jul; 13(7):506-11. PubMed ID: 7917509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins.
    Sadrieh N; Thomas PE
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):222-32. PubMed ID: 8048065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Sass DA; Rucinski B; Bryer HP; Mann GN; Yuan Z; Ma Y; Jee WS; Epstein S
    Bone; 1996 Oct; 19(4):381-6. PubMed ID: 8894144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
    Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
    Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
    Augustine JA; Zemaitis MA
    Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and morphological changes of the exocrine pancreas in ciclosporin-treated rats.
    Hirakawa K; Ohkuma S; Kuriyama K
    Eur Surg Res; 1991; 23(5-6):292-301. PubMed ID: 1724964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism of cyclosporin A with rabbit renal or hepatic microsomes: analysis by HPLC-FPIA and HPLC-MS.
    Pham-Huy C; Sadeg N; Becue T; Martin C; Mahuzier G; Warnet JM; Hamon M; Claude JR
    Arch Toxicol; 1995; 69(5):346-9. PubMed ID: 7654141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thyroxine on hyperkalemia and renal cortical Na+, K+ - ATPase activity induced by cyclosporin A.
    You CW; Park YH; Lee ES; Kim YJ; Shin SM; Park MO
    J Korean Med Sci; 2002 Oct; 17(5):625-32. PubMed ID: 12378013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats.
    Shehata M; el Nahas A; Barkworth E; Cope GH; Raftery AT
    Kidney Int; 1994 Sep; 46(3):726-32. PubMed ID: 7996794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.